Back to
Susquehanna International Group, LLP
ARCT
29 quarters
Position history for
Susquehanna International Group, LLP's holdings in Arcturus Therapeutics Holdings Inc.
Yes. Susquehanna International Group holds 47,557 shares of ARCT (Arcturus Therapeutics Holdings), worth $319,583, as of its Q2 2026 13F filing. It reduced the position by 156,457 shares (-76.7%) from Q1 2026. Susquehanna International Group has held ARCT since Q2 2019, across 29 quarterly 13F filings.
Current Value
$319,583
Current Shares
47,557
Total Value Change
-$68,417
Total Shares Change
+6,404
Quarter-by-Quarter History
Other major holders of ARCT: ARK Investment Management LLC, Federated Hermes, Inc.